Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Vonoprazon

Preclinical

NNational Cheng-Kung University Hospital

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2027

PreclinicalNot yet recruiting

Bleeding

NCT07772700

Clinical

Trials by Indication[1]

Bleeding1 trial

Potassium-competitive Acid Blocker Versus Double Dose Proton Pump Inhibitors in High High-risk Peptic Ulcer Bleeding: A Randomized Controlled Trial

Not yet recruiting·NNational Cheng-Kung University Hospital·Preclinical·NCT07772700·108 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Vonoprazon. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Vonoprazon. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — National Cheng-Kung University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: NNational Cheng-Kung University Hospital

Related News